MacroCautiousRegime · R3: company-level growth leadership is improving, but broad-market and technology momentum remain weak while the portfolio is 9.03% below its peak.

Tuesday plan: hold the live book while growth confirmation develops

Keep Monday's allocation unchanged for Tuesday morning. MSFT and NVDA showed stronger leadership in the completed session, but weak medium-term momentum in SPY, QQQ, AMZN, and NVDA keeps the portfolio in drawdown-review rather than full risk expansion.

  • 01AI and compute spending remain the main bridge between equity narratives and earnings power
  • 02Rate-path uncertainty is limiting confirmation across broad-market and technology benchmarks
  • 03AI financing and neocloud durability are becoming more important tests of demand quality
Read the dispatchPortfolio change · No position changes

Backed by research: EURUSD, Gold, and S&P 500 studies →

Holdings · Oct 27, 20265 positions, by weight
Archive

Previous entries

Daily macro dispatches and weekly recaps, newest first. Each records the portfolio changes published alongside it.

  1. 26Oct 2026MonMacroCautious

    Monday plan: hold the live book while growth leadership seeks confirmation

    The portfolio will enter Monday unchanged, with MSFT and NVDA carrying the growth thesis while XLE and XLV offset some of the pressure from weak market participation. Friday's relative performance was encouraging, but the 10.10% drawdown, weak technology momentum, and VIX at 19.45 keep conviction cautious.Portfolio change1 new • 1 exit
  2. 25Oct 2026SunWeeklyCautious

    Week in Review: Oil and AI Spending Split the Market Before the Fed

    A Thursday technology selloff erased an early rebound as investors challenged the cash cost of AI investment, while rising oil kept inflation risk alive. The S&P 500 and Nasdaq-100 ended lower, the Dow gained, and the regime remained R3 as leadership shifted toward health care, financials, and smaller companies.Portfolio changeWeekly recap
  3. 23Oct 2026FriMacroCautious

    Friday plan: hold the growth book steady while Thursday's sell-off is tested

    The Friday plan carries every holding and weight forward unchanged. Thursday exposed weak technology momentum and punished the portfolio's AI concentration, but the evidence doesn't yet invalidate the core earnings theses. The book remains in drawdown review, with MSFT carrying the highest conviction and META requiring the closest scrutiny.Portfolio change1 new • 1 exit
  4. 22Oct 2026ThuMacroCautious

    Thursday plan: keep the growth book unchanged while testing the AI rebound

    Thursday's morning plan carries the live portfolio forward without a resize. Wednesday's gains supported the existing growth exposure, led by NVDA and MRNA, but weak 20-day technology momentum, rate sensitivity, and META's legal risk keep the stance cautious.Portfolio change1 new • 1 trim
  5. 21Oct 2026WedMacroCautious

    Wednesday plan: hold the growth book while leadership remains uneven

    Keep MSFT at 29%, AMZN at 15%, NVDA at 26%, and META at 30%. Tuesday exposed weak relative performance, led by Meta, but the evidence doesn't justify a morning allocation change. Wednesday's open needs to show firmer participation from growth while MSFT and AMZN preserve their stronger medium-term trends.Portfolio changeNo position changes
Showing 5 of 172
Free investment journal

Follow the portfolio thinking, once a week.

Read the weekly market recap and investment journal. You can choose trading-session preparations separately.

Free. No paywall. Unsubscribe anytime.